Captor Therapeutics Spolka Akcyjna (WSE:CTX)
Poland flag Poland · Delayed Price · Currency is PLN
78.90
+1.90 (2.47%)
Jun 12, 2026, 5:00 PM CET

WSE:CTX Stock Forecast

Stock Price Forecast

The 3 analysts that cover WSE:CTX stock have a consensus rating of "Strong Buy" and an average price target of zł 86.83, which forecasts a 10.05% increase in the stock price over the next year. The lowest target is zł 67.00 and the highest is zł 110.00.

Price Target: zł 86.83 (+10.05%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Pricezł 67.00zł 86.83zł 83.50zł 110.00
Change-15.08%+10.05%+5.83%+39.42%

Analyst Ratings

The average analyst rating for WSE:CTX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy333333
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total333333

Financial Forecast

Revenue This Year
56.70M
from 4.66M
Increased by 1,116.74%
Revenue Next Year
48.50M
from 56.70M
Decreased by -14.46%
EPS This Year
-0.52
from -7.61
EPS Next Year
-0.26
from -0.52
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
3.99M9.16M13.20M15.83M4.66M56.70M
Revenue Growth
-129.75%44.15%19.88%-70.55%1,116.74%
Operating Income
-32.84M-38.36M-73.02M-38.97M-43.63M-3.10M
Net Income
-32.57M-35.89M-70.58M-38.43M-42.00M-3.00M
EPS
-----7.61-0.52
Free Cash Flow
-31.70M-17.25M-31.35M-52.76M-11.99M19.00M
No. Analysts
-----2
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is PLN.

Revenue Forecast

Revenue202620272028
High80.0M
Avg56.7M
Low33.4M

Revenue Growth

Revenue Growth202620272028
High
1,616.7%
Avg
1,116.7%
Low
616.7%

EPS Forecast

EPS202620272028
High3.07
Avg-0.52
Low-4.10

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-